Dr. Peter B. Dorschner, MD

Dr. Dorschner practices at Harvard Vanguard Medical Associates in Braintree, Massachusetts.

Dr. Dorschner's NPI, 1750770434, was assigned on January 17, 2015. Dr. Dorschner holds Massachusetts license 267756.

Dr. Dorschner's primary practice is Harvard Vanguard Medical Associates, at 111 Grossman Dr, Braintree, MA 02184 in Norfolk County. The practice phone is (617) 421-1000.

Dr. Dorschner's primary practice is Harvard Vanguard Medical Associates in Braintree, Massachusetts. Dr. Dorschner is also affiliated with Massachusetts General Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Dorschner to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dorschner practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dorschner's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dorschner is licensed in Massachusetts.

CMS data shows 2,346 Medicare services from Dr. Dorschner across 43 procedure codes in 2024, for 226 Medicare patients. Medicare paid $51,982 for them. Every service was in an office.

CMS counts 226 Medicare patients who saw Dr. Dorschner in 2024. The largest group is 65 to 74, with 104 patients. 73% of them have high blood pressure, and 72% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dorschner's median patient age at 56, with 44% women.

In 2024, Dr. Dorschner wrote 5,123 Medicare Part D claims for 400 patients. 84% of them were for generic drugs. CMS names the drug for 4,478 of them, across 101 drugs with 11 or more claims each, at $518,503 in total drug cost. In 2023, CMS named 4,975 claims across 116 drugs.

Dr. Dorschner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dorschner as offering telehealth.

Dmand AI links 4 papers to Dr. Dorschner, published from 2014 to 2019. The most frequent topics are Cross Infection, Liver Transplantation and Transplant Recipients. Dr. Dorschner has published most often in Transpl Infect Dis. Dr. Dorschner's most frequent co-authors are Madeleine R. Heldman, MD and Valentina Stosor, MD.

CMS Open Payments shows 1 general payment to Dr. Dorschner from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $25.